Ocular proton therapy: state-of-the-art
https://doi.org/10.21516/2072-0076-2023-16-3-147-151
Abstract
We present the current trends in proton therapy of patients with intraocular malignancies as reflected in the materials of the First PTCOG ocular proton therapy symposium, held on March 3–4, 2022.
Keywords
ophthalmic oncology,
proton therapy (PT),
clinical PT Center,
PT results,
treatment planning system (TPS),
dose delivery system,
quality assurance (QA) of the procedure
Supporting agencies: The authors are grateful to the researchers of the Institute of Theoretical and Experimental Physics
About the Authors
V. O. Karpunin
National Kurchatov Institute Research Center
Russian Federation
Russian Federation
Vladimir O. Karpunin - researcher, nuclear medicine department
1, Academician Kurchatov Sq., Moscow, 123182
D. G. Orlov
National Kurchatov Institute Research Center
Russian Federation
Russian Federation
Dmitry G. Orlov - Cand. of Phys.-Math. Sci., senior researcher, nuclear medicine department
1, Academician Kurchatov Sq., Moscow, 123182
V. S. Khoroshkov
National Kurchatov Institute Research Center
Russian Federation
Russian Federation
Vladimir S. Khoroshkov - Dr. of Tech. Sci., head of nuclear medicine department
1, Academician Kurchatov Sq., Moscow, 123182
References
1. Khoroshkov V.S. History and prospects of proton therapy. Мedical radiology and radiation safety. 2019; 64 (2): 52–60 (In Russ.). doi.org/10.12737/article_5ca5fc2765c9f5.02525917
2. Goitein G. Proton radiation therapy of ocular melanoma proton radiation therapy of ocular melanoma. Talk on the conference PTCOG-49. 2010 Available at: https://www.ptcog.ch/archive/conference_p&t&v/PTCOG49/presentationsEW/18-4-3_Eye.pdf (Accessed 23 May 2022).
3. Dendale R, Lumbroso-Le Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay Proton Therapy Center (ICPO). International journal of radiation oncology, biology, physics. 2006; 65 (3): 780–7.
4. Pica A, Weber DC, Vallat L, et al. Good long-term visual outcomes of parapapillary choroidal melanoma patients treated with proton therapy: a comparative study. Int Ophthalmol. 2021; Feb; 41 (2): 441–52.
5. Borodin J.I., Valsky V.V., Saakyan S.V., et al. Proton therapy for intraocular and orbital malignant tumors. Almanac of clinical medicine. 2008; 17–1: 292–5 (In Russ.).
6. Borodin Yu.I., Valsky V.V., Erokhin I.N., et al. Technical innovations for proton therapy of intraocular neoplasms. Part I. Russian ophthalmological journal. 2015; 8 (2): 14–20 (In Russ.).
7. Borodin Yu.I., Valsky V.V., Erokhin I.N., et al. Technical innovations for proton therapy of intraocular neoplasms. Part II. Russian ophthalmological journal. 2016; 9 (2): 11–7 (In Russ.). doi.org/10.21516/2072-0076-2016-9-2-11-17
Review
For citations:
Karpunin V.O., Orlov D.G., Khoroshkov V.S. Ocular proton therapy: state-of-the-art. Russian Ophthalmological Journal. 2023;16(3):147-151. (In Russ.) https://doi.org/10.21516/2072-0076-2023-16-3-147-151
Views:
275
Email this article 